Skip to content
OpenCapital
Get started

Johnson & Johnson JNJ Innovative Medicine — Percent Change (as a percent)

Similar metrics at other companies

DXP Enterprises logo
DXPEInnovative Pumping Solutions — Revenue change in percentage
37.7%—
DXP Enterprises logo
DXPEInnovative Pumping Solutions — Revenue change
$32.48M—
Equifax logo
EFXInternational — Change in revenue (as a percent)
11%+10.0pp
CBAK Energy Technology, Inc. logo
CBATIncrease Percentage
2%—
Equifax logo
EFXU.S. Information Solutions — Change in revenue (as a percent)
21%+14.0pp
Boston Scientific logo
BSXMedSurg — Research and development expenses, percentage of net sale
7.5%0.0pp

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$623.71B+66.9%
Enterprise value$657.01B+61.9%
P/E29.6×+13.2×
P/S6.5×+2.3×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept jnj:PercentageChangeInSalesBySegmentOfBusiness.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's innovative medicine — percent change (as a percent).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's innovative medicine — percent change (as a percent)?
Johnson & Johnson (JNJ) reported innovative medicine — percent change (as a percent) of 32% in Q1 2026.
How has Johnson & Johnson's innovative medicine — percent change (as a percent) changed year-over-year?
Johnson & Johnson's innovative medicine — percent change (as a percent) increased by 43.5% year-over-year, from 22.3% to 32%.
What is the long-term trend for Johnson & Johnson's innovative medicine — percent change (as a percent)?
Over 2 years (2022 to 2025), Johnson & Johnson's innovative medicine — percent change (as a percent) has grown at a 163.0% compound annual growth rate (CAGR), from 9.9% to 68.5%.
What does innovative medicine — percent change (as a percent) mean?
Calculates the period-over-period growth rate of the Innovative Medicine segment's sales. This metric normalizes performance to show the velocity of revenue expansion or contraction. It is essential for benchmarking the segment's growth against industry peers and internal targets.